Immunome, Inc. (IMNM)
21.84
-0.61
(-2.72%)
USD |
NASDAQ |
Apr 02, 16:00
21.95
+0.11
(+0.50%)
After-Hours: 20:00
Immunome Market Cap : 2.400B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Krystal Biotech, Inc. | 7.684B |
| Scholar Rock Holding Corp. | 5.821B |
| Stoke Therapeutics, Inc. | 1.981B |
| Nurix Therapeutics, Inc. | 1.599B |
| CytomX Therapeutics, Inc. | 984.69M |
Market Cap Related Metrics
| PS Ratio | 273.26 |
| Price to Book Value | 3.895 |
| Price | 21.84 |
| Earnings Yield | -11.12% |